SUBSCRIBE
SUBSCRIBE
News   Deals

IOMAI Corporation Cuts IPO To 5 Million Shares At $7-$9 Each

January 30, 2006 | 
1 min read
WASHINGTON, Jan 30 (Reuters) - Biopharmaceutical company Iomai Corp. on Monday cut its planned initial public offering to 5 million shares at $7 to $9 each from 6.25 million at between $11 and $13.
IPO
MORE ON THIS TOPIC
Aggressive obstacle from the boss. Concept illustration. Vector illustration
Obesity
Is Metsera Worth the Fuss?
November 5, 2025
 · 
4 min read
 · 
Annalee Armstrong
Business concept illustration of a businessman being pointed by giant fingers
Earnings
Novo Execs Face Skeptical Analysts Amid Metsera Buyout Drama
November 5, 2025
 · 
5 min read
 · 
Annalee Armstrong
A businessman hold a ladder, he tried to break through barriers to move forward
Earnings
Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera
November 4, 2025
 · 
5 min read
 · 
Annalee Armstrong
Money trap and business risks, insurance concept. Vector of greedy businessman running to the bait, another man trying stop him.
Mergers & acquisitions
Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid
November 4, 2025
 · 
1 min read
 · 
Annalee Armstrong